Vertex PharmaceuticalsVRTX 
$408.180.72%24h
0.72%24h
Global rank133
Market cap$105.19B
Change 7d-11.52%
YTD Performance-
SP500 benchmark
P/E29.39
P/S10.66
Revenue$9.87B
Earnings$3.62B
Dividend yield-
Main Sector
Healthcare
Vertex Pharmaceuticals (VRTX) Net Assets
VRTX Net Assets in 2024: $17.58B
As of 12 Jan 2025, Vertex Pharmaceuticals net assets is $17.58B, an increase of 26.36% to 2023. Net assets are calculated as total assets minus total liabilities. This value represents the Vertex Pharmaceuticals overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.
Vertex Pharmaceuticals Net Assets History from 2018 to 2025
-
Value:-
VRTX Net Assets History by year
| Year | Net assets | Change |
|---|---|---|
| 2023 | $17.58B | 26.36% |
| 2022 | $13.91B | 37.75% |
| 2021 | $10.10B | 16.27% |
| 2020 | $8.69B | 42.75% |
| 2019 | $6.09B | -303.77% |
| 2018 | $-2.99B | - |
View the Top Net Assets Companies
